LivaNova UK Limited

Information

Name

LivaNova UK Limited

Type

Company

Roles

Supplier

Company Size

Large

Company Number

Incorporation Date

Website

https://etendersni.gov.uk/epps

Address

1370 Monpellier Court, Gloucester Business Park

Gloucester
GL3 4AH
United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with LivaNova UK Limited
Sign up free

Contracts awarded to LivaNova UK Limited

The contracts that LivaNova UK Limited have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 4 months ago

Blood Cardioplegia Sets

Blood Cardioplegia Sets

£436,000
Award

Published 8 months ago

Wound Drainage, Autologous Blood Systems and Related Accessories

The scope of this Framework Agreement is to cover the supply of products and their associated consumables and accessories for Wound Drainage, Post Operative and Intra Operative Autologous Blood System products. Precise quantities are unknown. It is anticipated that initial expenditure will be circa £3,450,000 in the first year of this Framework Agreement; however, this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value of the total Framework Agreement term (including any extension options) is circa £6,900,000.

£6,900,000 Bids close: 11 months ago
Award

Published 8 months ago

Wound Drainage, Autologous Blood Systems and Related Accessories

The scope of this Framework Agreement is to cover the supply of products and their associated consumables and accessories for Wound Drainage, Post Operative and Intra Operative Autologous Blood System products. Precise quantities are unknown. It is anticipated that initial expenditure will be circa £3,450,000 in the first year of this Framework Agreement; however, this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. The estimated value of the total Framework Agreement term (including any extension options) is circa £6,900,000.

£2,350,000
Award

Published 11 months ago

Neuromodulation Devices and Associated Products 2023

Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route Ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps, Dorsal Ramus Medial Branch nerve and other devices that provide nerve stimulation or pain management that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £92,000,000.00 the term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £392,000,000.00. Additional information: Located in attachments is a Daft version of the Framework Agreement

£392,000,000 Bids close: 1 year ago
Award

Published 11 months ago

Neuromodulation Devices Consumables and Associated Products 2023

"Non-exclusive Framework Agreement (FAG) for the supply to the NHS Supply Chain customer base via the E-Direct Route. Product range to include, but not limited to stimulation of; Deep Brain, Spinal Cord, Sacral Nerve, Vagal Nerve, Dorsal Route Ganglion, Peripheral Nerve, Radio Frequency Pain Management, Intrathecal Brug Delivery Pumps, Dorsal Ramus Medial Branch nerve and other devices that provide nerve stimulation or pain management that meet the requirements of users and patients. The FAG will provide access to Neuromodulation Devices/Consumables that are associated with Neuromodulation procedures. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £92,000,000.00 the term of FAG, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the FAG. The estimated value over the total FAG term (including any extension options) is £392,000,000.00"

£392,000,000

Contacts

[email protected]

+44 1452638500

Statistics (1 Year)

Contracts Won

Total Won

£436,000

Average Win

£436,000

LivaNova UK Limited

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to LivaNova UK Limited

Blood Cardioplegia Sets

Wound Drainage, Autologous Blood Systems and Related Accessories

Wound Drainage, Autologous Blood Systems and Related Accessories

Neuromodulation Devices and Associated Products 2023

Neuromodulation Devices Consumables and Associated Products 2023

Contacts

Statistics (1 Year)

Contracts Won

Total Won

Average Win